M

Mach7 Technologies
M7T

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$144.51M
EV
A$122.56M
Shares Outstanding
236.09M
Beta
1.36
Industry
Medical - Healthcare Information Services

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
3
P/E 2026E
-
P/Revenue 2026E
4.02x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
-
Net Profit Margin 2026E
-13.77%
ROE 2026E
-14.92%
ROCE 2025
-12.73%

Dividends

DPS 2026E
A$0.00
Payout Ratio 2026E
0.00%
Div. Yield 2026E
0.00%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Mach7 Technologies Limited

gainify

M

Mach7 Technologies Limited

M7T

Mach7 Technologies Limited develops and commercializes medical imaging and data management software solutions for healthcare organizations in North America, the Asia Pacific, the Middle East, Europe, and internationally. It offers eUnity enterprise diagnostic viewer, ...

Sector

Healthcare

Industry

Medical - Healthcare Information Services

CEO

Thomas, Teri

Employees

IPO Date

2005-11-29

Headquarters

120 Kimball Avenue, Suite 210, South Burlington, Vermont, 05403, United States

📊 Stock Price & Performance

The last closing price of Mach7 Technologies (M7T) is A$0.62, reflecting a +7.90% change from the prior session. Last updated: December 31, 2025 at 10:11 PM Eastern Time

Review the recent M7T stock performance trends:Past 1 Month: Mach7 Technologies (M7T) shares have +36.67%.Past 3 Months: The stock has +105.00%.Past 6 Months: M7T shares have +86.36%. Last updated: December 31, 2025 at 11:36 PM Eastern Time

Over the last year, Mach7 Technologies (M7T) has established a 52-week price range between a high of A$0.62 and a low of A$0.28. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:36 PM Eastern Time

Mach7 Technologies (M7T) is considered a medium volatility stock. It has a beta of 1.36, which means it typically moves 1.36 times as much as the broader market. Over the past 52 weeks, M7T has traded within a A$0.28 – A$0.62 range. Last updated: December 31, 2025 at 11:36 PM Eastern Time

Based on current M7T analyst forecasts and market assumptions, the consensus price target for Mach7 Technologies (M7T) is A$0.69 for 2027. Relative to the current price of A$0.62, this implies a positive upside of +11.45%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:36 PM Eastern Time

A A$1,000 investment in Mach7 Technologies 5 years ago, when the stock was trading around A$1.26, would be worth approximately A$491.87 today, based solely on share price performance (excluding dividends). This represents a total return of -50.81% over the period, equivalent to a compound annual growth rate (CAGR) of -13.23%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:36 PM Eastern Time

💰 Financial Metrics & Reports

The current Mach7 Technologies (M7T) market capitalization is approximately A$144.51M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Mach7 Technologies's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:36 PM Eastern Time

In the most recently reported quarter, Mach7 Technologies (M7T) generated A$8.02M in revenue, representing a +1.60% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:08 AM Eastern Time

In the most recently reported fiscal year, Mach7 Technologies (M7T) generated net income of A$-6.20M, compared with A$-7.97M in the prior fiscal year, representing a +22.19% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of A$-4.95M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:08 AM Eastern Time

According to its latest quarterly filing, Mach7 Technologies (M7T) reported EBITDA of A$-2.10M, representing a +3.07% year over year change. EBITDA is a non-GAAP measure and does not account for depreciation, amortization, interest expense, taxes, or capital expenditures. As a result, it should be considered alongside other financial metrics when assessing operating performance. Actual results may differ from estimates as company-specific or macroeconomic conditions evolve. Last updated: January 1, 2026 at 2:08 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.02x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 2:08 AM Eastern Time

Based on the latest available data, Mach7 Technologies (M7T) is currently trading at a last twelve months (LTM) P/E ratio of -23.55x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 2:08 AM Eastern Time

📅 Earnings & Dividends

Mach7 Technologies (M7T) is currently scheduled to report its next earnings results on February 24, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:36 PM Eastern Time

In the most recently reported quarter, Mach7 Technologies (M7T) revenue was A$8.02M. Earnings per share (EPS) for the quarter were A$-0.01. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:08 AM Eastern Time

Mach7 Technologies (M7T) does not currently pay a dividend. Over the last twelve months (LTM), the company paid A$0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future. Last updated: January 1, 2026 at 2:08 AM Eastern Time

📈 Analyst Information

Analyst assessments of whether Mach7 Technologies (M7T) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: A$0.62Consensus price target: A$0.69Implied return: +11.45% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 2:08 AM Eastern Time

Based on the latest available analyst coverage, Mach7 Technologies (M7T) currently carries a Buy consensus rating. Analysts' average M7T price target is A$0.69. Relative to the current share price of A$0.62, this suggests a potential price change of approximately +11.45%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 2:08 AM Eastern Time

Like other publicly traded stocks, Mach7 Technologies (M7T) shares are bought and sold on stock exchanges such as ASX and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Mach7 Technologies (M7T) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add M7T to your watchlist.

Mach7 Technologies trades under the ticker symbol M7T on the ASX stock exchange. The ticker M7T is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Mach7 Technologies (M7T) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Mach7 Technologies (M7T) stock peers based on overlapping products, services, and competitive dynamics:DarioHealth (DRIO)VSee Health (VSEE)BrainAurora Medical Technology (6681)MeVis Medical Solutions (M3V)Beijing Airdoc Technology (2251)Pro Medicus (PME)Physitrack (PTRK) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Mach7 Technologies.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.